NCT02363322: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02363322 |
|---|---|
| Title | A Multicenter Randomized Safety and Efficacy Study of Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 13, 2015 |
| Completion date | Dec. 31, 2017 |
| Required reporting date | Dec. 31, 2018, midnight |
| Actual reporting date | Aug. 7, 2018 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |